Cargando…

Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection

BACKGROUND. Acute perivascular rejection (AR) is common in lung recipients and increases the risk for chronic lung allograft dysfunction (CLAD). Hyaluronan (HA), an extracellular matrix constituent, accumulates in experimental AR and can act as an innate immune agonist, breaking tolerance and potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Hostetler, Haley P., Neely, Megan L., Kelly, Francine L., Belperio, John A., Budev, Marie, Reynolds, John M., Shah, Pali D., Singer, Lianne G., Snyder, Laurie D., Palmer, Scott M., Todd, Jamie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440013/
https://www.ncbi.nlm.nih.gov/pubmed/34549083
http://dx.doi.org/10.1097/TXD.0000000000001138
_version_ 1783752624692002816
author Hostetler, Haley P.
Neely, Megan L.
Kelly, Francine L.
Belperio, John A.
Budev, Marie
Reynolds, John M.
Shah, Pali D.
Singer, Lianne G.
Snyder, Laurie D.
Palmer, Scott M.
Todd, Jamie L.
author_facet Hostetler, Haley P.
Neely, Megan L.
Kelly, Francine L.
Belperio, John A.
Budev, Marie
Reynolds, John M.
Shah, Pali D.
Singer, Lianne G.
Snyder, Laurie D.
Palmer, Scott M.
Todd, Jamie L.
author_sort Hostetler, Haley P.
collection PubMed
description BACKGROUND. Acute perivascular rejection (AR) is common in lung recipients and increases the risk for chronic lung allograft dysfunction (CLAD). Hyaluronan (HA), an extracellular matrix constituent, accumulates in experimental AR and can act as an innate immune agonist, breaking tolerance and potentiating alloimmunity. We previously demonstrated HA accumulates in CLAD after human-lung transplantation. We sought to determine if HA accumulates in the bronchoalveolar lavage fluid (BALF) concurrent with AR in lung recipients. METHODS. The cohort consisted of 126 first adult lung recipients at 5 transplant centers with a total of 373 BALF samples collected within the first posttransplant year. All samples were paired with a lung biopsy from the same bronchoscopy. BALF HA (ng/mL) was quantified by ELISA and log-transformed for analysis. Linear-mixed effect models, adjusted for potential confounders, were used to estimate the association between BALF HA concentration and the presence of AR on biopsy. The association between early posttransplant BALF HA levels and the development of CLAD was explored utilizing tertiles of maximum BALF HA level observed within the first 6 months of transplant. RESULTS. In analyses adjusted for potential confounders, BALF HA concentration was significantly increased in association with AR (change in means on log-scale 0.31; 95% CI, 0.01-0.60; P = 0.044). When considered on the original scale (ng/mL), BALF HA concentrations were 1.36 times (36%) higher, on average, among samples with, versus without, AR. The cumulative incidence of CLAD was numerically higher in individuals in the highest tertiles of BALF HA level within the first 6 months after transplant, as compared with those in the lowest tertile; however, this difference was not statistically significant (P = 0.32). CONCLUSIONS. These results demonstrate accumulation of HA in clinical AR and suggest a mechanism by which innate and adaptive immune activation might interact in the development of AR and CLAD.
format Online
Article
Text
id pubmed-8440013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-84400132021-09-20 Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection Hostetler, Haley P. Neely, Megan L. Kelly, Francine L. Belperio, John A. Budev, Marie Reynolds, John M. Shah, Pali D. Singer, Lianne G. Snyder, Laurie D. Palmer, Scott M. Todd, Jamie L. Transplant Direct Lung Transplantation BACKGROUND. Acute perivascular rejection (AR) is common in lung recipients and increases the risk for chronic lung allograft dysfunction (CLAD). Hyaluronan (HA), an extracellular matrix constituent, accumulates in experimental AR and can act as an innate immune agonist, breaking tolerance and potentiating alloimmunity. We previously demonstrated HA accumulates in CLAD after human-lung transplantation. We sought to determine if HA accumulates in the bronchoalveolar lavage fluid (BALF) concurrent with AR in lung recipients. METHODS. The cohort consisted of 126 first adult lung recipients at 5 transplant centers with a total of 373 BALF samples collected within the first posttransplant year. All samples were paired with a lung biopsy from the same bronchoscopy. BALF HA (ng/mL) was quantified by ELISA and log-transformed for analysis. Linear-mixed effect models, adjusted for potential confounders, were used to estimate the association between BALF HA concentration and the presence of AR on biopsy. The association between early posttransplant BALF HA levels and the development of CLAD was explored utilizing tertiles of maximum BALF HA level observed within the first 6 months of transplant. RESULTS. In analyses adjusted for potential confounders, BALF HA concentration was significantly increased in association with AR (change in means on log-scale 0.31; 95% CI, 0.01-0.60; P = 0.044). When considered on the original scale (ng/mL), BALF HA concentrations were 1.36 times (36%) higher, on average, among samples with, versus without, AR. The cumulative incidence of CLAD was numerically higher in individuals in the highest tertiles of BALF HA level within the first 6 months after transplant, as compared with those in the lowest tertile; however, this difference was not statistically significant (P = 0.32). CONCLUSIONS. These results demonstrate accumulation of HA in clinical AR and suggest a mechanism by which innate and adaptive immune activation might interact in the development of AR and CLAD. Lippincott Williams & Wilkins 2021-03-22 /pmc/articles/PMC8440013/ /pubmed/34549083 http://dx.doi.org/10.1097/TXD.0000000000001138 Text en Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lung Transplantation
Hostetler, Haley P.
Neely, Megan L.
Kelly, Francine L.
Belperio, John A.
Budev, Marie
Reynolds, John M.
Shah, Pali D.
Singer, Lianne G.
Snyder, Laurie D.
Palmer, Scott M.
Todd, Jamie L.
Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
title Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
title_full Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
title_fullStr Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
title_full_unstemmed Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
title_short Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
title_sort intragraft hyaluronan increases in association with acute lung transplant rejection
topic Lung Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440013/
https://www.ncbi.nlm.nih.gov/pubmed/34549083
http://dx.doi.org/10.1097/TXD.0000000000001138
work_keys_str_mv AT hostetlerhaleyp intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT neelymeganl intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT kellyfrancinel intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT belperiojohna intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT budevmarie intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT reynoldsjohnm intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT shahpalid intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT singerlianneg intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT snyderlauried intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT palmerscottm intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection
AT toddjamiel intragrafthyaluronanincreasesinassociationwithacutelungtransplantrejection